Table 2.

Correlation of STAT family members with tumor stages of NSCLC patients

Gene	Stages	Low (cases)	High (cases)	HR (95% CI)	p-value
STAT1	I	288	289	0.83 (0.63-1.09)	0.18
	II	122	122	0.75 (0.52-1.08)	0.12
	III	35	35	0.79 (0.46-1.36)	0.39
STAT2	I	293	284	1.25 (0.96-1.64)	0.1
	II	122	122	1.64 (1.14-2.37)	0.0078*
	III	35	35	0.55 (0.32-0.96)	0.033*
STAT3	I	288	289	1.38 (1.05-1.81)	0.02*
	II	122	122	1.45 (1-2.09)	0.049*
	III	35	35	1.57 (0.91-2.7)	0.1
STAT5A	I	288	289	0.76 (0.58-1)	0.052
	II	122	122	0.9 (0.63-1.3)	0.59
	III	35	35	0.93 (0.53-1.61)	0.79
STAT5B	I	288	289	0.45 (0.33-0.6)	6.5e-08**
	II	122	122	0.83 (0.57-1.2)	0.32
	III	35	35	0.67 (0.39-1.16)	0.15
STAT6	I	288	289	0.45 (0.33-0.6)	3.7e-08**
	II	122	122	0.89 (0.62-1.29)	0.55
	III	35	35	0.51 (0.29-0.89)	0.016*

Low/High (cases): low/high expression of the corresponding gene (patient number).

^* P < 0.05;

^** P < 0.01.